IntelliChem Sets New Standard for Intelligent Electronic Lab Notebooks.

Business Editors/Health, Medical & High-Tech Writers

BEND, Ore.--(BUSINESS WIRE)--April 20, 2004

IntelliChem Delivers the Industry's First Global Intelligent ELN 

Platform to Span Across Discovery and Development

IntelliChem, Inc., the leading provider of intelligent electronic lab notebooks (iELN) for discovery and development, has redefined the market for electronic lab notebooks by delivering the industry's first intelligent solution to span drug discovery, development, formulations, analytical, and bioprocess organizations. For the first time, pharmaceutical and biotechnology companies can deploy a single ELN platform across their entire global research & development organization.

Already chosen by five of the top ten pharmaceutical companies in the world, IntelliChem Discovery & Development Solutions, Version 4.2 (IDS v4.2) further expands the breadth of IntelliChem's product offerings, introducing new suites for analytical and bioprocess chemists. In addition, IntelliChem has strengthened its market-leading suites for drug discovery, development, and formulations.

"AstraZeneca is adopting IntelliChem Synthesis as the product of choice," said Ian Menzies, Information Manager, Process Research and Development at AstraZeneca. "We look at IntelliChem as the platform for the future, providing our scientists with a set of well designed and integrated tools that will help us to improve productivity and efficiency. This latest release is simply the best ELN product available on the market today."

IntelliChem Discovery & Development Solutions are comprised of six product suites that are specifically tailored to streamline business processes in all major areas of research and development. Every IntelliChem product shares the same multi-tiered architecture, creating a flexible and consistent global platform for the management of laboratory and procedural data. These intelligent ELN solutions not only allow pharmaceutical companies to replace paper lab notebooks, but they also provide decision-support tools to help chemists and engineers make better decisions.

IntelliChem Discovery 4.2

Designed specifically to improve the quality of drug candidates, quality of information, and quality of life for medicinal chemists, IntelliChem Discovery is the industry's most comprehensive ELN solution for drug discovery. Using either a simple, one-page electronic editor or a more structured editor, medicinal chemists can easily replace their paper lab notebooks with a fully searchable electronic system that enables collaboration across sites and departments, while enabling parallel experimentation. Medicinal chemists and their managers will benefit while planning and executing laboratory procedures, creating focused libraries, preparing for meetings, writing patent applications, managing their notebooks, and registering new compounds.

IntelliChem Synthesis 4.2

IntelliChem Synthesis is already in use at many of the world's leading pharmaceutical companies as they strive to improve complex recipe management and streamline GMP documentation for the clinical supply chain. IntelliChem Synthesis provides process chemists and engineers with the tools required to better learn from past experiments, construct complex recipes, plan and execute laboratory procedures, plan multi-step process scenarios, scale reactions, and choose feasible and economical routes. In addition, consistent, automated reporting dramatically reduces the time and effort required to prepare batch records for GMP documentation.

IntelliChem Formulations 4.2

Designed specifically to solve the challenges faced by formulators, IntelliChem Formulations is the leading intelligent ELN and decision-support suite for pharmaceutics departments. IntelliChem Formulations saves time, improves information and formulation quality, and enables full traceability while giving scientists and engineers immediate access to all formulation details. Through integration with other IntelliChem Suites, it allows formulators to dramatically improve handoffs with discovery, process, and analytical chemists, while enabling smoother tech transfers.

IntelliChem Methods 4.2

Designed to meet the rigorous documentation needs of analytical laboratories, IntelliChem Methods provides a fully searchable intelligent ELN system for recording and analyzing laboratory data. Using IntelliChem Methods, analytical chemists can record and track standard sample preparation and analysis procedures for reuse throughout laboratories and departments. IntelliChem Methods enhances the efficiency and efficacy of analytical chemists by simplifying the documentation of routine analyses, providing a fully searchable database of procedures and results, and by seamlessly integrating with the rest of the scientific community.

IntelliChem BioProcess 4.2

IntelliChem BioProcess is the first intelligent ELN built specifically for bioprocess engineers dealing with biological development. Bioprocess engineers will benefit at multiple stages of the development process, including tracking samples though different stages of fermentation and purification, preparing multi-step bioprocess protocols, preparing documentation, and learning from the past.

IntelliChem Research 4.2

Designed to be a low-cost entry point for small biotechnology and pharmaceutical companies, IntelliChem Research consists of a simple, one page electronic editor that replaces paper lab notebooks, along with the Vault AXD Management Platform. Together, they create a complete entry-level solution for chemists working in drug discovery and development.

Vault AXD Management Platform 4.2

The Vault AXD Management System supports all IntelliChem Suites with a fully searchable and regulatory compliant document management system. In addition to managing MS Word, MS Excel, and other standard document types, the Vault AXD Management Platform also stores Active eXperimental Documents (AXDs), which are structured documents maintained as XML data objects. By storing AXDs, the system enables complete searchability, automated comprehension by computers and machines, and the ability to drive multiple views, analyses, and reports without the need to reformat the stored data. With a flexible security model, full traceability, and support for electronic signatures, the Vault AXD Management Platform enables full compliance with federal regulations, including Title 21 CFR Part 11.

"This release of IntelliChem Discovery & Development Solutions provides our global customers the platform for their future R&D strategies," said Matt Wallach, Vice President of Marketing & Strategic Product Management at IntelliChem. "The ability to deploy a single software platform across both their discovery and development organizations will lead to breakthrough levels of global efficiency, productivity, and collaboration."

IntelliChem Discovery & Development Solutions Version 4.2 (IDS v4.2) is available for immediate shipment.

About IntelliChem

IntelliChem, Inc. is the leading provider of intelligent electronic lab notebooks (iELN) for discovery and development. Pharmaceutical, biotechnology, and fine chemicals companies can improve productivity, enable collaboration, improve quality, and ensure regulatory compliance through the adoption of IntelliChem solutions. IntelliChem Discovery & Development Solutions (IDS) were developed and validated through partnership with six major pharmaceutical companies, including Merck & Co., Pfizer, and Bristol-Myers Squibb. IntelliChem is a privately held company with headquarters and development facilities located in Bend, Oregon. For more information, visit www.intellichem.com.